About JJP Biologics
We are a private biopharmaceutical company developing innovative personalized therapies to treat autoimmune diseases and cancer. Our lead program JJP-1212 is being developed to treat the rare disease linear IgA bullous dermatosis but also other severe diseases where pathogenic IgA is involved (both rare and non-rare).